Women and men differ biologically in ways that go far beyond reproductive anatomy. From the genetic instructions encoded on the X chromosome to how the liver breaks down a common painkiller, sex shapes the body’s structure, chemistry, and disease risk at nearly every level. Many of these differences have only been characterized in the last two decades, partly because biomedical research historically defaulted to male subjects and male cells. The result is a growing catalog of sex-based findings that matter for how diseases are diagnosed, how drugs are dosed, and why certain conditions strike one sex harder than the other.
What the X Chromosome Contributes Beyond Reproduction
Every cell in a woman’s body carries two X chromosomes, while every cell in a man’s body carries one X and one Y. To avoid a double dose of X-linked gene products, one of a woman’s two X chromosomes is largely silenced early in development. But the silencing is incomplete. A meaningful number of genes “escape” inactivation and remain active on both copies, giving women higher expression of those genes compared to men. Research suggests these escape genes play a role in the evolution of sex-specific traits and may be responsible for some of the differences seen when the number of X chromosomes is atypical.1PubMed Central. Genes that escape from X inactivation
The picture gets more complex at the single-cell level. The degree to which genes escape X inactivation varies across cell types and tissues, meaning that the sex difference in gene expression is not uniform throughout the body. Immune cells, for example, may show a different escape profile than liver cells. This cell-type-specific heterogeneity helps explain why sex differences in disease risk are not distributed evenly across organ systems.2Cell Genomics. Quantification of escape from X chromosome inactivation with single-cell omics data reveals heterogeneity across cell types and tissues
A Stronger Immune System and Its Trade-Offs
Women mount more vigorous immune responses to many infections. When researchers measured antibody responses to a seasonal influenza vaccine in a group of men and women, women consistently produced higher antibody levels and showed elevated inflammatory signaling molecules in their blood, regardless of age.3PubMed Central. Systems analysis of sex differences reveals an immunosuppressive role for testosterone in the response to influenza vaccination That same pattern extends to respiratory viruses more broadly: women appear better equipped to fight off viral lung infections, with estrogen and other sex hormones influencing both antibody production and T cell activity.4PubMed Central. Immunological aspects and gender bias during respiratory viral infections including novel Coronavirus disease-19 (COVID-19): A scoping review
This immune advantage has a flip side. Men are more susceptible to severe viral illness and certain cancers, but women’s more aggressive immune surveillance can turn inward, making them more prone to autoimmune conditions.5PubMed Central. Sex differences in tissue-specific immunity and immunology Women have higher baseline levels of circulating antibodies than men, and that heightened antibody production is closely tied to autoimmune disease risk. The link is reinforced by several observations: men with an extra X chromosome (Klinefelter syndrome) also show increased antibody levels and autoimmune disease, antibody levels and autoimmunity both spike in the months after childbirth, and the risk of autoimmune disease rises with the number of pregnancies a woman has had.6PubMed Central. Why women have more autoimmune diseases than men: An evolutionary perspective
From an evolutionary perspective, the heightened antibody production in women likely evolved to protect offspring from infection during pregnancy and breastfeeding. The autoimmune susceptibility is, in a sense, collateral damage of a system tuned for defense. Beyond hormones, genetic factors on the X chromosome, microchimerism from pregnancy (where fetal cells persist in the mother’s body), and lifestyle differences all contribute to the female predominance in conditions like rheumatoid arthritis and lupus.7PubMed Central. Why are women predisposed to autoimmune rheumatic diseases?
Cardiovascular Disease Looks Different in Women
Heart disease is the leading killer of both sexes, but it develops and presents differently. Before menopause, women enjoy a degree of cardiovascular protection attributed to estrogen, which supports blood vessel flexibility and favorable cholesterol profiles. Once estrogen levels drop at menopause, that protection fades and cardiovascular risk climbs.8PubMed Central. Menopause and women’s cardiovascular health: is it really an obvious relationship?
The nature of the disease often differs too. When women undergo evaluation for suspected heart-related chest pain, a “normal” finding on angiography is about five times more common than it is in men. That does not mean the pain is imaginary. Many of these women have microvascular angina, a condition where the tiny coronary arteries malfunction even though the large vessels look clear on imaging.9PubMed Central. Microvascular angina: angina that predominantly affects women Microvascular disease is more common in women and carries a real risk of future cardiovascular events, yet it has historically been underdiagnosed because the standard diagnostic workup was designed around the large-vessel blockages more typical in men.10PubMed. Coronary microvascular disease in women: epidemiology, mechanisms, evaluation, and treatment
Drug Metabolism and the Dosing Problem
Women and men process many medications at different rates. The liver enzyme CYP3A4, which handles over half of all commonly prescribed drugs, is more active in women than in men.11PubMed. Gender-related differences in pharmacokinetics and their clinical significance Other liver enzymes differ in the opposite direction, with several being more active in men. These differences in enzyme activity are a major driver of sex-based variation in how quickly drugs are cleared from the body.12PubMed Central. Sex differences in the expression of hepatic drug metabolizing enzymes
The practical consequence is that women experience adverse drug reactions roughly twice as often as men. A study evaluating 86 drugs found that 76 of them showed higher blood concentrations or slower clearance in women. Among the 59 drugs with identifiable side effects, the direction of the difference in drug processing predicted the direction of the sex difference in side effects about 88% of the time. And the asymmetry runs deep: for drugs that stayed in women’s bodies longer, nearly all were associated with more side effects in women, but the reverse pattern in men was much weaker.13PubMed Central. Sex differences in pharmacokinetics predict adverse drug reactions in women A large part of the problem is historical: most drugs on the market were approved based on trials conducted primarily in men, so standard dosing may effectively overmedicate women for many compounds.
Brain Organization and Neurological Disease
Male brains are larger on average, but when you adjust for total volume, women have a higher proportion of gray matter (the cell bodies that do the processing) and men have a higher proportion of white matter (the cabling that connects regions). Women also have higher overall blood flow to the brain. Neurochemically, the two sexes show distinct profiles in dopamine, serotonin, and GABA signaling systems.14PubMed Central. Evolving Knowledge of Sex Differences in Brain Structure, Function and Chemistry
Functional brain imaging has begun to map where these differences play out in real-time activity. The default mode network, active during rest and self-reflection, and the striatum, involved in reward processing and reinforcement learning, both show sex-specific patterns of activation. Differences in the limbic network, particularly in regions that process reward value and pleasure, may contribute to sex-specific patterns in hedonic experience and emotional processing.15PubMed Central. Exploring the Impact of Sex and Gender in Brain Function: Implications and Considerations It is worth noting, though, that when researchers looked at brain structure in children aged 9 to 11, the proportion of variation explained by sex alone was small, and much of the apparent difference in white matter and cortical folding was accounted for by total brain volume rather than sex itself.16PubMed Central. Sex, gender diversity, and brain structure in early adolescence
These structural and chemical differences have implications for neurological disease. Parkinson’s disease, for example, strikes men at roughly twice the rate it strikes women, yet women who do develop it tend to progress faster and have higher mortality. The symptoms, treatment responses, and even the risk factors differ between the sexes, suggesting that the disease may involve partially distinct biological pathways in men and women.17PubMed Central. Parkinson’s Disease in Women and Men: What’s the Difference?
Pain Processing Uses Different Molecular Machinery
Chronic pain conditions are more common in women, and emerging evidence suggests the reason goes deeper than differences in pain tolerance or reporting. In rodent studies, the molecular pathways that sustain chronic pain turn out to be partially sex-specific. Males rely heavily on spinal cord microglia (a type of immune cell in the central nervous system) to maintain pain hypersensitivity, while females depend more on calcitonin gene-related peptide (CGRP) and the hormone prolactin and its receptor.18PubMed. Sex differences in mechanisms of pain hypersensitivity Additional pathway analysis hints that females and males may even use different branches of the T cell immune response to drive chronic pain states.19PubMed Central. Sex differences in neuroimmune and glial mechanisms of pain
This has direct implications for drug development. A painkiller designed to block microglial activation might work well in men but miss the mark in women entirely, while a drug targeting CGRP (a class of migraine drugs already on the market) may be disproportionately effective in women. The field is still early, but the lesson is clear: treating pain as a one-mechanism problem leaves sex-specific biology unaddressed.
Fat Storage, Insulin Resistance, and Liver Disease
Women carry more total body fat than men on average, but they store it differently. Women deposit more fat under the skin (subcutaneous fat), while men accumulate a higher ratio of fat around the organs (visceral fat). This distinction matters metabolically. In a study of overweight and obese middle-aged and older adults, men were about 47% more insulin resistant than women despite carrying less total fat, partly because their higher visceral fat load drives metabolic dysfunction more aggressively.20PubMed Central. Sex differences in insulin action and body fat distribution in overweight and obese middle-aged and older men and women The relationship between fat type and insulin resistance also differs by sex: in men, both subcutaneous and visceral abdominal fat contribute similarly to insulin resistance, whereas in women, visceral fat is the dominant driver.21PubMed. Associations of Abdominal Subcutaneous and Visceral Fat with Insulin Resistance and Secretion Differ Between Men and Women: The Netherlands Epidemiology of Obesity Study
These metabolic differences extend to the liver. A large meta-analysis found that women have about a 19% lower risk of developing nonalcoholic fatty liver disease than men in the general population. But when women do develop it, the disease can behave more aggressively: women showed a 37% higher risk of progressing to advanced fibrosis. Age amplifies the disparity. In study populations with an average age of 50 or older, women’s risk of both inflammatory liver disease (NASH) and advanced scarring was substantially higher than men’s, a pattern consistent with the loss of estrogen’s protective effects after menopause.22PubMed Central. Women Have a Lower Risk of Nonalcoholic Fatty Liver Disease but a Higher Risk of Progression vs Men: A Systematic Review and Meta-analysis
Why Women Work Harder to Breathe During Exercise
For a given lung size, women have narrower conducting airways than men. This anatomical mismatch, called dysanapsis, means that air meets more resistance flowing through a woman’s airways, particularly during heavy breathing.23PubMed. Revisiting dysanapsis: sex-based differences in airways and the mechanics of breathing during exercise During exercise, the practical result is that women expend more energy and oxygen on the act of breathing itself. Researchers confirmed that the higher work of breathing in women during exercise is driven by this increased airway resistance and that the difference persists even after accounting for lung volume, pointing to a true sex-based difference in airway caliber rather than simply a size issue.24PubMed Central. Dysanapsis and the resistive work of breathing during exercise in healthy men and women
For most recreational exercisers, this difference is invisible. But at high ventilation rates, women are more likely to hit mechanical limits on how much air they can move, which can cap performance in endurance sports and alter the whole-body response to intense aerobic work.
Bone Loss and the Estrogen Cliff
Estrogen is a key regulator of bone turnover in both sexes, but its loss hits women harder and faster. Estrogen suppresses the activity of bone-resorbing cells while promoting the growth of bone-building cells. When estrogen drops sharply at menopause, the balance tips toward bone breakdown.25PubMed Central. Osteoporosis Due to Hormone Imbalance: An Overview of the Effects of Estrogen Deficiency and Glucocorticoid Overuse on Bone Turnover Over the decade surrounding menopause, women lose roughly 9% of bone mineral density at the hip and about 11% at the spine.26PubMed. Estrogen and bone health in men and women Men lose bone too as they age, but the decline is slower and less dramatic because they never experience a comparable hormonal cliff.
Muscle Fiber Composition
Skeletal muscle is not identical between the sexes. A large meta-analysis found that women have a higher proportion of type I (slow-twitch) muscle fibers, while men have a higher proportion of type II (fast-twitch) fibers. Men’s individual muscle fibers are also larger in both categories. The difference in fiber-type distribution means women’s muscles are, on average, slightly better suited to sustained low-intensity work and fatigue resistance, while men’s muscle profile favors explosive power.27PubMed Central. Sex differences in human skeletal muscle fiber types and the influence of age, physical activity, and muscle group: A systematic review and meta-analysis
Cancer Treatment Response and Immune Checkpoint Drugs
The sex difference in immunity has a surprising extension into cancer treatment. Immune checkpoint inhibitors, drugs that unleash the immune system against tumors, appear to work better in men than in women. A meta-analysis of randomized trials testing checkpoint inhibitors as standalone treatment found that the survival benefit was larger in men than in women in 19 out of 20 trials analyzed. The pooled reduction in the risk of death was roughly twice as high in men, regardless of the cancer type or the specific drug used.28Cancer Cell. Sex and cancer immunotherapy: Current understanding and challenges
Part of the explanation may lie in the tumor itself. In melanoma and bladder cancer, male patients had significantly higher tumor mutation burdens, meaning their tumors carry more genetic alterations that the immune system can recognize as foreign.29Nature Communications. Sex-associated molecular differences for cancer immunotherapy More mutations generally mean more targets for the immune system, which could help explain why checkpoint drugs that remove the brakes on immunity deliver a bigger payoff in male patients. For women, whose immune systems are already more active at baseline, the calculus of “releasing the brakes” may simply produce a different magnitude of additional benefit.
Telomeres, Estrogen, and the Longevity Gap
Women outlive men in virtually every country on earth. The gap is probably driven by multiple overlapping factors, but one line of research focuses on telomeres, the protective caps on the ends of chromosomes that shorten with each cell division. Women tend to have longer telomeres than men, and estrogen appears to be part of the reason: it can activate telomerase, the enzyme that rebuilds telomere length.30PubMed. The longevity gender gap: are telomeres the explanation? Studies in medaka fish, which share the female-longer-than-male telomere pattern seen in humans, found that estrogen levels correlated with both telomerase activity and telomere length in female organs but not in male ones, and that females experienced a menopause-like estrogen decline with aging that paralleled telomere shortening.31PubMed Central. Medaka fish exhibits longevity gender gap, a natural drop in estrogen and telomere shortening during aging: a unique model for studying sex-dependent longevity Telomeres alone do not explain the longevity gap, but they represent one biological thread in a web that also includes hormonal protection against cardiovascular disease, stronger immune surveillance, and differences in oxidative stress.
The Gut Microbiome as a Sex Hormone Target
The trillions of bacteria in the gut are not immune to sex hormone influence. Estrogen shapes the gut environment in multiple ways: it affects how immune cells in the intestinal wall develop, prolongs the survival of antibody-producing B cells, and alters intestinal permeability. The resulting changes to the local immune environment can influence which bacterial species thrive and how the gut barrier functions.32Journal of Neurogastroenterology and Motility. Roles of Sex Hormones and Gender in the Gut Microbiota This connection may help explain why conditions linked to gut dysbiosis, including certain autoimmune diseases and irritable bowel syndrome, show different prevalence rates in women and men. It also raises the possibility that hormonal shifts at menopause or during pregnancy reshape the gut microbiome in ways that ripple outward to metabolic and immune health.
Why Research Is Still Catching Up
For decades, biomedical research treated the male body as the default. Female animals were excluded from preclinical studies over concerns that hormonal cycles would add variability. Women were underrepresented in clinical trials. In 2016, the U.S. National Institutes of Health introduced its “Sex as a Biological Variable” (SABV) policy, requiring grant applicants to account for sex in study design. A recent analysis of NIH-funded research found that while about 61% of studies now include both sexes, only 44% of those actually analyze their data by sex. Studies led by women were more likely to perform sex-based analyses, and articles with women as both first and last authors were more than twice as likely to break their results down by sex compared to other authorship combinations.33Communications Medicine. Incorporation of the National Institute of Health (NIH) sex as a biological variable policy by R01 grant awardees The policy shifted behavior in some labs, with over a third of surveyed researchers reporting that they changed their study designs to comply, but receiving NIH funding did not by itself make researchers more likely to actually analyze results by sex.34PubMed Central. Biomedical Researchers’ Perceptions of the NIH’s Sex as a Biological Variable Policy for Animal Research: Results from a U.S. National Survey Including both sexes and analyzing by sex are two different things, and the gap between them means that sex-specific findings are still being left on the table in a large share of publicly funded studies.